| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/23/1994 | EP0587639A1 Pharmaceutical compositions |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | EP0502032B1 Delayed release formulations |
| 03/23/1994 | EP0458939B1 STABILIZATION OF t-PA pro |
| 03/23/1994 | CN1084080A Collagen-based pharmaceutical compositions |
| 03/23/1994 | CN1084079A Ophthalmic compositions |
| 03/23/1994 | CN1084064A Formulations containing hyaluronic acid |
| 03/23/1994 | CN1084062A Composition for treating pain, method for treaing pain and composition for reinforcing pain relief action |
| 03/23/1994 | CN1084060A Slowly-released external use powder and its prepn. |
| 03/22/1994 | US5296594 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 03/22/1994 | US5296572 Mixing unsaturated or alkenoylamine with dimethylacrylamide, crosslinker, water, adding emulsifier, adding organic phase, agitating, adding initiator, adjusting pH, adding promoter, polymerizing, isolating polyamide beads |
| 03/22/1994 | US5296475 Methanediphosphonic acids and crown compounds for treatment of bone disorders or hypercalcemia |
| 03/22/1994 | US5296246 Active amino acid Ca, beverages containing same, and process for their production |
| 03/22/1994 | US5296245 Culture product |
| 03/22/1994 | US5296237 Water-soluble pharmaceutical metallocene-complex composition |
| 03/22/1994 | US5296235 Plaster preparation |
| 03/22/1994 | US5296228 Compositions for controlled delivery of pharmaceutical compounds |
| 03/22/1994 | US5296225 Topically applying preparation containing capsaicin to skin overlying trigeminal and cervical nerves |
| 03/22/1994 | US5296222 An enzyme such as proteolytic enzyme to enhance penetration |
| 03/22/1994 | US5296219 Process for coating active principles using a pH-sensitive polymer |
| 03/22/1994 | CA1327936C Phospholipase a_ inhibiting compositions and their use |
| 03/18/1994 | EP0575613A4 Pharmaceutical preparation of antistress, stress-preventive and nootropic action. |
| 03/17/1994 | WO1994005702A1 Extraction of collagen |
| 03/17/1994 | WO1994005631A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs |
| 03/17/1994 | WO1994005624A1 Cationic lipids |
| 03/17/1994 | WO1994005336A1 Film-forming x-ray contrast compositions |
| 03/17/1994 | WO1994005332A2 Glycolation of glycosylated macromolecules |
| 03/17/1994 | WO1994005331A1 Stable, highly concentrated formulations of fluorescein derivatives |
| 03/17/1994 | WO1994005325A1 Vaccines against group c neisseria meningitidis |
| 03/17/1994 | WO1994005312A1 Medical preparations containing n-methylated cyclic undecapeptides |
| 03/17/1994 | WO1994005297A1 Drugs containing diphosphonic acids and salts thereof |
| 03/17/1994 | WO1994005286A1 Ready-to-inject azosemide solutions |
| 03/17/1994 | WO1994005266A1 Local drug delivery film for periodontal treatment |
| 03/17/1994 | WO1994005265A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 03/17/1994 | WO1994005261A1 Anhydrous topical compositions which dry rapidly on contact |
| 03/17/1994 | WO1994005259A1 Method of encapsulating anthracycline glycosides in liposomes |
| 03/17/1994 | WO1994005258A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof |
| 03/17/1994 | WO1994005203A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
| 03/17/1994 | DE4230504A1 Stabile kosmetische Mittel Stable cosmetic products |
| 03/17/1994 | CA2143115A1 Stable highly concentrated formulations of fluorescein derivatives |
| 03/17/1994 | CA2142493A1 An antivirally active pharmaceutical oil-in-water emulsion containing 9-¬(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof |
| 03/16/1994 | EP0587431A1 Bioerodible contraceptive suppository |
| 03/16/1994 | EP0587357A2 New chain-terminated N-vinyl lactam polymers and graft-copolymers and methods for making same |
| 03/16/1994 | EP0587264A1 Aqueous pharmaceutical formulations of sodium cromoglycate |
| 03/16/1994 | EP0587137A1 Adsorbate comparised of an auxiliary agent mixture and a non-solid active agent for the manufacture of pharmaceutical preparations |
| 03/16/1994 | EP0587121A1 Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof |
| 03/16/1994 | EP0587047A2 Gestagenes containing pharmaceutical composition |
| 03/16/1994 | EP0587002A1 Preservative agent containing thymol and/or carvacrol for injectable formulations |
| 03/16/1994 | EP0586838A1 Method for producing sustained release microsphere preparation |
| 03/16/1994 | EP0586694A1 Process and device for low-emission spraying. |
| 03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586528A1 Polydeoxyribonucleic acid based pharmaceutical compounds and method for preparing same |
| 03/16/1994 | EP0586524A1 Improvements in or relating to contrast agents. |
| 03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
| 03/16/1994 | EP0586501A1 N-acyl derivatives of amino acid mixtures derived from cereal protein hydrolysates and applications thereof. |
| 03/16/1994 | EP0586381A1 Improved blood substitute |
| 03/16/1994 | EP0450080B1 Composition for the treatment of progressive myopia |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/16/1994 | EP0368912B1 Polyanhydrides with improved hydrolytic degradation properties |
| 03/16/1994 | CN1083822A Polyoxymethylene-oxyethylene copolymers in conjuction with biomolecules |
| 03/16/1994 | CN1083728A Taste-masking composition of bitter pharmaceutical agents |
| 03/16/1994 | CN1083703A Pharmaceutical composition with functions of antialcohol, promoting change of energy, of mucosa of stomach, acidification, secretion, antradiation and anticholera |
| 03/15/1994 | US5294607 Artificial tear film of complex phospholipid over the aqueous eye layer and an overlayer of nonpolar oil |
| 03/15/1994 | US5294536 Conjugates |
| 03/15/1994 | US5294448 Sustained release drugs |
| 03/15/1994 | US5294447 Anhydrous topical compositions which dry rapidly on contact |
| 03/15/1994 | US5294440 Imidazole-4-ethanamine phosphate for treatment of Herpes lesions |
| 03/15/1994 | US5294249 Polymer blend of gelatin and starch in water, forming hydrogen bonds and cooling |
| 03/15/1994 | CA2105629A1 Potentiation of immunogenic response |
| 03/15/1994 | CA1327748C Pharmaceutical composition containing ranitidine and alginic acid |
| 03/13/1994 | CA2106038A1 Physiologically active peptide composition |
| 03/12/1994 | CA2105913A1 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions |
| 03/09/1994 | EP0586282A1 Topical compositions containing 5-methoxypsoralene |
| 03/09/1994 | EP0586238A2 Method of producing sustained-release microcapsules |
| 03/09/1994 | EP0586106A1 Skin care compositions containing imidazoles and retinoids |
| 03/09/1994 | EP0586034A2 High pullulan content product, and its preparation and uses |
| 03/09/1994 | EP0585688A2 Aqueous dispersions of zein and controlled release coatings derived therefrom |
| 03/09/1994 | EP0585570A1 Antigranulocyte antibody construct, preparation and use thereof |
| 03/09/1994 | EP0585436A1 Immobilization of chemical species in crosslinked matrices |
| 03/09/1994 | EP0585415A1 Dna encoding a human 5-ht 1e? receptor and uses thereof |
| 03/09/1994 | EP0585412A1 Increasing blood-brain barrier permeability with permeabilizer peptides |
| 03/09/1994 | EP0585345A1 Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h 2?o 2? |
| 03/09/1994 | EP0585252A1 Pharmaceutical formulations |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0585224A1 MONOCLONAL ANTIBODIES WHICH BIND TO SECRETED AND MEMBRANE-BOUND IgE, BUT NOT TO IgE ON BASOPHILS |
| 03/09/1994 | EP0437487B1 Targetting agents |
| 03/09/1994 | CN1083392A Collagen-containing sponges as drug delivery for proteins |
| 03/09/1994 | CN1083383A Analgesic health-care plaster for external use and its preparation method |
| 03/09/1994 | CN1083355A Local drug delivery film for periodontal treatment |
| 03/09/1994 | CN1023933C Controlled release pharmaceutical preparation and method for producing the same |
| 03/09/1994 | CA2101571A1 Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof |
| 03/08/1994 | US5292868 Chelating agents for attaching metal ions to proteins |
| 03/08/1994 | US5292867 Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin |
| 03/08/1994 | US5292802 Collagen-polymer tubes for use in vascular surgery |
| 03/08/1994 | US5292528 Oral Composition |
| 03/08/1994 | US5292525 Method and composition for removing an alginate from a cutaneous substrate |
| 03/08/1994 | US5292521 And an organic acid or salt |
| 03/08/1994 | US5292518 Prolonged-release drug tablet formulations |
| 03/08/1994 | US5292517 pH sensitive, reversible gelling, copolymeric erodible drug delivery system |